107 related articles for article (PubMed ID: 36230734)
21. Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
Shah SD; Gillard BM; Wrobel MM; Karasik E; Moser MT; Mastri M; Long MD; Sule N; Brackett CM; Huss WJ; Foster BA
Front Oncol; 2023; 13():1120329. PubMed ID: 36816919
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance.
Diep S; Maddukuri M; Yamauchi S; Geshow G; Delk NA
Cells; 2022 May; 11(10):. PubMed ID: 35626710
[TBL] [Abstract][Full Text] [Related]
23. TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB.
Xing J; Chen W; Chen K; Zhu S; Lin F; Qi Y; Zhang Y; Han S; Rao T; Ruan Y; Zhao S; Yu W; Cheng F
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230734
[TBL] [Abstract][Full Text] [Related]
24. Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer.
Hu CY; Su BH; Lee YC; Wang CT; Yang ML; Shen WT; Fu JT; Chen SY; Huang WY; Ou CH; Tsai YS; Kuo FC; Shiau AL; Shieh GS; Wu CL
J Biomed Sci; 2022 Dec; 29(1):104. PubMed ID: 36471329
[TBL] [Abstract][Full Text] [Related]
25. ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals.
Huang CP; Chen J; Chen CC; Liu G; Zhang Y; Messing E; Yeh S; Chang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):275. PubMed ID: 31234917
[TBL] [Abstract][Full Text] [Related]
26. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
[TBL] [Abstract][Full Text] [Related]
27. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
Li C; Su H; Ruan C; Li X
Folia Histochem Cytobiol; 2021; 59(1):40-48. PubMed ID: 33577073
[TBL] [Abstract][Full Text] [Related]
28. BRD4 promotes the migration and invasion of bladder cancer cells through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
Liu T; Zhang Z; Wang C; Huang H; Li Y
Biochem Cell Biol; 2022 Apr; 100(2):179-187. PubMed ID: 35167374
[TBL] [Abstract][Full Text] [Related]
29. Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression.
Xia Y; Yu W; Cheng F; Rao T; Ruan Y; Yuan R; Ning J; Zhou X; Lin F; Zheng D
Front Oncol; 2021; 11():701122. PubMed ID: 34733776
[TBL] [Abstract][Full Text] [Related]
30. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.
Lánczky A; Győrffy B
J Med Internet Res; 2021 Jul; 23(7):e27633. PubMed ID: 34309564
[TBL] [Abstract][Full Text] [Related]
31. A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity.
Wenmaekers S; Viergever BJ; Kumar G; Kranenburg O; Black PC; Daugaard M; Meijer RP
Cells; 2021 May; 10(5):. PubMed ID: 34065298
[TBL] [Abstract][Full Text] [Related]
32. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract][Full Text] [Related]
34. Bladder Cancer: A Review.
Lenis AT; Lec PM; Chamie K; Mshs MD
JAMA; 2020 Nov; 324(19):1980-1991. PubMed ID: 33201207
[TBL] [Abstract][Full Text] [Related]
35. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
